Under-editing of glutamate ionotropic receptor AMPA type subunit 2 (GRIA2) has been reported to play a role in glioma aggressive phenotype (Maas et al., 2001; Oakes et al., 2017). Here, GRIA2 is linked to central nervous system cancer.